Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Refine results:

Refine results

White Papers

Results 81–90 of 92

Device Development for Pharmaceutical and Biologic Combo Products

| Contributed by Philips-Medisize

Developing a combination product, there are many things to consider. With early design involvement, there is a greater opportunity for success.

Finding the optimal formulation: Thermal and chemical unfolding studies using nanoDSF

| Contributed by Nano Temper

Bayer Pharma AG uses thermal and chemical unfolding experiments with nanoDSF to find optimal buffer conditions for IgG antibodies.

Easy Solutions for Difficult Targets: Thermal Unfolding of GPCRs

| Contributed by Nano Temper

In a collaborative study with Novartis Institutes for Biomedical Research, a thermal unfolding assay using nanoDSF is applied to understanding the stabilizing effects of ligands on G protein-coupled receptors. See how nanoDSF provides an easy solution for this difficult target.

Revolutionize Biosimilar Screening Processes with nanoDSF

| Contributed by Nano Temper

nanoDSF is a new and powerful tool for rapid screening approaches in biosimilar development. It enables narrowing down the number of promising candidates in hours instead of days or weeks. Download the full application note to learn more.

Looking into the crystal ball: predicting the aggregation propensity of antibodies

| Contributed by Nano Temper

Fully automated analysis of antibody formulations using chemical and thermal denaturation

Thermal unfolding of antibodies

| Contributed by Nano Temper

Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

SafeliaTM Autoinjector Designed to be Patient and Syringe Friendly.

| Contributed by Nemera

Nemera’s has developped a new generation of 2-steps autoinjector for fluid and viscous injections.

Advancia®: the only breakthrough nasal spray pump in over ten years.

| Contributed by Nemera

The only user-independent multi-dose nasal spray system on the market

How to have an appropriate delivery system to save time in nasal spray development programs?

| Contributed by Nemera

Nemera’s Device Equivalence Program has been established to respond to market enquiries in terms of nasal spray equivalence and second-sourcing needs

Glass to plastic: a gas barrier PFS for biologics

| Contributed by Nemera

An innovative prefilled syringe (PFS) for biopharmaceutical products

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register